Comment from TSS Inc
AnonymousSupportIndividual
Summary: The commenter, a founding member of the National Drug and Alcohol Screening Association (NDASA), supports the proposed expansion of 510(k) exemptions for certain Class II medical devices. They argue that the current FDA regulatory pathway is a mismatch for forensic workplace drug testing and advocate for transferring oversight to the National Laboratory Certification Program to improve public safety and modernize testing.
Please accept my support of the comments submitted by the National Drug and Alcohol Screening Association (NDASA) pertaining to FDA-2026-N-4268. As a founding member of that association, I am keenly aware of the need to transfer oversight of drug testing devices to the National Laboratory Certification Program. Critical testing for workplace safety is being held up by the current process and movement needs to happen to improve the safety level of the traveling public. I have attached the NDASA comment, as well.